CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...